Abstract:Contrast-enhanced ultrasound has shown convincing results for monitoring vessel morphology, surrogate markers of vascularization and changes in molecular marker expression in oncological and cardiovascular diseases. Ultrasound contrast agents have the ability to increase the backscattering signal intensity of an ultrasound pulse. An interesting class of ultrasound contrast agents are gas filled microbubbles, which can be synthesized by external bubble encapsulation using sugar matrices or microspheres consisting of lipids or polymers with or without surfactant and by selecting gases with low blood solubility and diffusion coefficient such as perfluorocarbons or sulphur hexafluoride. Ultrasound contrast agents can be classified according to the rigidity of their shell. Soft-shell microbubbles are coated with a thin monolayer of surfactant molecules such as palmitic acid or phospholipids and are very sensitive to pressure changes. Hard-shell microbubbles have a rigid shell made of polymers such as polycyanoacrylate, which dramatically increases their stability. Depending on the acoustic properties of the microbubbles and on the purpose of the examination either destructive or non destructive methods are preferred for their detection. Microbubbles can be detected by destructive and non-destructive methods. Both soft- and hard-shell microbubbles coated with target-specific molecules can also be used for molecular imaging. Using target-specific approaches, the expression of several angiogenic markers such as VEGFR2, alphavbeta3 Integrins, ICAM, and E-selectin has been investigated in neoplastic and vascular diseases. This article summarizes the synthesis and properties of contrast agents as well as the indications, limitations and future potential of contrast-enhanced functional and molecular ultrasound.

Microbubbles and ultrasound: from diagnosis to therapy

Ultrasound Microbubbles for Molecular Diagnosis, Therapy, and Theranostics

Ultrasound Microbubbles for Diagnosis and Treatment of Cardiovascular Diseases

Ultrasound microbubble contrast agents: Application to therapy for peripheral vascular disease

Nano/Microparticles And Ultrasound Contrast Agents

Introduction of Ultrasound Microbubble Technology Aided Tumor Imaging and Treatment

Characterization of Contrast Agent Microbubbles for Ultrasound Imaging and Therapy Research

Development and New Clinical Applications of Ultrasound Microbubble Contrast Agents

Biogenic Gas Vesicles for Ultrasound Imaging and Targeted Therapeutics

Encapsulated ultrasound microbubbles: Therapeutic application in drug/gene delivery

Ultrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery

Functional and Molecular Ultrasound Imaging: Concepts and Contrast Agents

Lipid-based microbubbles and ultrasound for therapeutic application

Application of Ultrasound Microbubbles in Cardiovascular Diseases

PrEPArAtION OF A tHErAPEUtIc ULtrAsOUND cONtrAst AGENt Composition of a Microbubble Components of a Microbubble Shell

Ultrasound-mediated diagnostic imaging and advanced treatment with multifunctional micro/nanobubbles.

Ultrasound-mediated Diagnostic Imaging and Advanced Treatment with Multifunctional Micro/nanobubbles

Microbubbles for human diagnosis and therapy

Progress and preclinical application status of ultrasound microbubbles

Advanced Microbubbles As a Multifunctional Platform Combining Imaging and Therapy

Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery